Janna Lawrence

Janna joined Bristows as a trainee solicitor in August 2018. She completed training in September 2020 and is now working in the commercial IP/IT team.

First CRISPR therapy seeks regulatory approval, but will it be able to avoid the pitfalls of other cell and gene therapies?

Seminar: Value recognition in AI transactions – Bristows and One Nucleus panel event

AI – commercial models and value recognition in life sciences transactions

View more from Janna

Associate

Credentials

Related Articles

First CRISPR therapy seeks regulatory approval, but will it be able to avoid the pitfalls of other cell and gene therapies?

Seminar: Value recognition in AI transactions – Bristows and One Nucleus panel event

AI – commercial models and value recognition in life sciences transactions

Inquisitive minds